Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
03 March 2015

 
03 March 2015
Although a short month, February didn’t lack for medtech approvals: 63 passed Clinica’s news desk, up from 60 in February 2014, and only just short of the 65 seen in January. The February 2015 approvals, split by geography, as shown in Table 1, ...
03 March 2015
In this second instalment of Auditor’s Oratory, where notified bodies share their experience and advice on coping with the evolving EU medtech regulatory climate, Paul Sim* of BSI explains how unannounced audits are changing the job of notified ...
02 March 2015
Johnson & Johnson, the one-time leader in the heart stent sector, has decided to leave this device space for good, selling its Cordis business to Cardinal Health for nearly $2bn. Fremont, California-based Cordis had annual sales in 2014 of ...
02 March 2015
Clinica recorded 20 medtech acquisitions in February, up from 17 in the same month last year but down from 26 in January 2015. But like January, February was a relatively low-spending month. Excluding Pfizer’s $17bn move to acquire Hospira, which ...
 
03 March 2015
Johnson & Johnson has opened the doors of its latest incubator, JLABS @South San Francisco (JLABS @SSF), welcoming its first resident start-ups. While JLABS @SSF will eventually hold 50 companies in total, the first 10 start-ups include MiNDERA, a ...
03 March 2015
Although a short month, February didn’t lack for medtech approvals: 63 passed Clinica’s news desk, up from 60 in February 2014, and only just short of the 65 seen in January. The February 2015 approvals, split by geography, as shown in Table 1, ...
02 March 2015
Johnson & Johnson, the one-time leader in the heart stent sector, has decided to leave this device space for good, selling its Cordis business to Cardinal Health for nearly $2bn. Fremont, California-based Cordis had annual sales in 2014 of ...
02 March 2015
Not long after rival Medtronic made an acquisition in the urology sector, Boston Scientific has followed suit, agreeing to buy American Medical Systems’ urology portfolio from Endo International. The deal is worth $1.6bn upfront and up to $50m in ...
 
02 March 2015
Johnson & Johnson, the one-time leader in the heart stent sector, has decided to leave this device space for good, selling its Cordis business to Cardinal Health for nearly $2bn. Fremont, California-based Cordis had annual sales in 2014 of ...
02 March 2015
Not long after rival Medtronic made an acquisition in the urology sector, Boston Scientific has followed suit, agreeing to buy American Medical Systems’ urology portfolio from Endo International. The deal is worth $1.6bn upfront and up to $50m in ...
02 March 2015
Clinica recorded 20 medtech acquisitions in February, up from 17 in the same month last year but down from 26 in January 2015. But like January, February was a relatively low-spending month. Excluding Pfizer’s $17bn move to acquire Hospira, which ...
27 February 2015
Neuromodulation specialist Cyberonics, which has just agreed to merge with Sorin, got a further boost by seeing its top and bottom lines both expand during its third fiscal quarter. The company’s sales increased 6% to $72.1m, while net income grew ...
 
03 March 2015
Is exposure to bisphenol A (BPA), a chemical used to produce certain plastics such as polycarbonates and epoxy resins, via medical devices safe? Are there any risks? Those are the questioned tackled by the European Commission’s Scientific Committee ...
03 March 2015
In this second instalment of Auditor’s Oratory, where notified bodies share their experience and advice on coping with the evolving EU medtech regulatory climate, Paul Sim* of BSI explains how unannounced audits are changing the job of notified ...
02 March 2015
The European Commission has set up a new 3D printing group to look into the regulatory issues that are emerging in this rapidly developing area. The group is part of the commission’s broader working group on New and Emerging Technologies (NET), and ...
02 March 2015
Medtech companies doing business in Thailand could look forward to the relaxation of certain regulatory requirements as part of the country’s efforts to harmonize its current regulations with the ASEAN Medical Device Directive. Thailand’s main ...
 
Carefusion CEO joins Edwards’ board Edwards Lifesciences has elected to its board of directors Kieran Gallahue, chairman and CEO of CareFusion. Mr Gallahue will take the seat of ...
Lombard gets AtriCure chief on board Lombard Medical, the specialist in endovascular aneurysm repair, has appointed Michael Carrel to its board of directors. Mr Carrel is currently ...
Canada’s Xagenic taps Abbott for product development leader Xagenic, a privately-held molecular diagnostics company, has appointed Tom Waddell vice-president of product development. Dr Waddell was most ...
20 February 2015
Ashley Yeo

The forthcoming 2 March session of the EU council ’s working party on pharmaceuticals and devices will be the sixth time that the WP has sat and debated elements of the proposed Medical Devices and In Vitro Diagnostics Regulations under the current ...

11 February 2015
Ashley Yeo

Turning good intentions into fact and deed is very much on the minds of those who lead the main US medical technology industry association, AdvaMed . Turning bad ideas out into the snow is also a major preoccupation, according to senior figures at ...

 
20 February 2015
Ashley Yeo

The forthcoming 2 March session of the EU council ’s working party on pharmaceuticals and devices will be the sixth time that the WP has sat and debated elements of the proposed Medical Devices and In Vitro Diagnostics Regulations under the current ...

11 February 2015
Ashley Yeo

Turning good intentions into fact and deed is very much on the minds of those who lead the main US medical technology industry association, AdvaMed . Turning bad ideas out into the snow is also a major preoccupation, according to senior figures at ...

30 January 2015
Ashley Yeo

Who wields the power in the delivery of healthcare? Not the government, not the regulators and not the doctors – not thisweek in Germany, in any case. A Dear Patient letter from the managers of the Westphalia-Lippe Association of Statutory Health ...

 
21 January 2015
Madeleine Armstrong

Liquid biopsies have shown great promise in detecting and monitoring cancer. One contender, Trovagene, tells Clinica why it believes it has the edge over other companies in the space One of the current goals in oncology is monitoring cancer “from ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
09 February 2015

Clearbridge BioMedics Specialty area(s): Circulating tumor cell capture technology Based in: Singapore Founded in: 2010 No. of employees: 20 Total investment received to date: Undisclosed Investors: Clearbridge BSA, SPRING Seeds Capital, ...

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
 
© 2015 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36